Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

IGBA Calls on all Stakeholders to Join the Biosimilars… 1 November 2021 Read more
The European Commission needs to prioritise equitable access… 25 January 2022 Over 15 years ago, the world’s first biosimilar was launched.…
Review of Nitrosamine Drug Substance Related Impurities… 30 October 2023 Nitrosamines are organic compounds with a chemical structure R2N-N=O (Figure…
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…